JP Morgan Chase’s Allergan Inc AGN Stock Holding History

JP Morgan Chase’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,942,623	Closed	-$413M	–	4542
2014 Q4	$413M	Buy	1,942,623 +492,143	+34%	+$97.9M	0.09%	239
2014 Q3	$258M	Sell	1,450,480 -599,171	-29%	-$99.5M	0.06%	343
2014 Q2	$347M	Sell	2,049,651 -1,610,190	-44%	-$251M	0.09%	258
2014 Q1	$454M	Sell	3,659,841 -774,897	-17%	-$94.4M	0.13%	185
2013 Q4	$493M	Buy	4,434,738 +108,635	+3%	+$10.4M	0.14%	165
2013 Q3	$391M	Sell	4,326,103 -1,707,301	-28%	-$153M	0.12%	209
2013 Q2	$508M	Buy	+6,033,404	New	+$626M	0.16%	136

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

JP Morgan Chase's AGN Position: Q1 2015 in Review

JP Morgan Chase sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,942,623 shares — an estimated $413M sold.

JP Morgan Chase first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $508M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

JP Morgan Chase reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
JP Morgan Chase sold 1,942,623 Allergan Inc shares in Q1 2015, an estimated $413M.
JP Morgan Chase first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
JP Morgan Chase's Allergan Inc position peaked at $508M in Q2 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on JP Morgan Chase's 13F filing for Q1 2015, filed 15 May 2015.